About Revolution Bioengineering
Revolution Bioengineering is a company based in Fort Collins (United States) founded in 2013. Revolution Bioengineering has raised $60 thousand across 1 funding round from investors including SOSV. Revolution Bioengineering offers products and services including Color Changing Flowers and Gardening Tools. Revolution Bioengineering operates in a competitive market with competitors including GSK, Benson Hill, Avidity Biosciences, Sutro Biopharma and Antheia, among others.
- Headquarter Fort Collins, United States
- SectorsHealthcareAgriculture
- Website revolutionbio.co
- Social LinkedIn X Facebook
- Total Equity Funding$60K (USD)
in 1 rounds
- Latest Funding Round$60K (USD), Seed
Jul 2014
- Investors
Products & Services of Revolution Bioengineering
Revolution Bioengineering offers a comprehensive portfolio of products and services, including Color Changing Flowers and Gardening Tools.
Engineered flowers that change colors to enhance garden visuals and sustainability.
Resources for planting and maintaining eco-friendly gardens with bioart elements.
Funding Insights of Revolution Bioengineering
Revolution Bioengineering has successfully raised a total of $60K through 1 strategic funding round. The most recent funding activity was a Seed round of $60 thousand completed in July 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $60,000
- Total Rounds 1
- Last Round Seed — $60,000
- First Round $60,000
(Jul 2014)
- Investors Count 1
All 1 funding rounds of Revolution Bioengineering with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2014 | $60,000 | Seed | – | SOSV | – |
1 investors in total: 1 institutional.
Investors in Revolution Bioengineering
Revolution Bioengineering has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include SOSV.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital and accelerator services are provided across multiple sectors. | – | sosv.com | Cork, Ireland |
Investor details for Revolution Bioengineering
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Revolution Bioengineering
2 dated milestones of Revolution Bioengineering across 1 years, from founding to its latest funding, stage changes and deals.
- Founded Revolution Bioengineering is founded.
- Funding First funding round of $60K.
Competitors of Revolution Bioengineering
Revolution Bioengineering operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Benson Hill, Avidity Biosciences, Sutro Biopharma and Antheia, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| gsk.com | 1715 | Brentford, United Kingdom | – | 90,913 | Developer of pharmaceuticals and vaccines for various therapeutic areas | |
| bensonhill.com | 2012 | St. Louis, United States | $406.99M | 151 | Provider of plant-based food ingredients | |
| aviditybiosciences.com | 2012 | San Diego, United States | $142.54M | 253 | Antibody-siRNA complexes are developed for cancer treatment. | |
| sutrobio.com | 2003 | United States | $171.85M | 235 | Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. | |
| antheia.bio | 2013 | Palo Alto, United States | $152.37M | 50 | Yeast cells are genetically engineered to produce medicinal products. | |
| vividion.com | 2016 | Oceanside, United States | $270.5M | 123 | Developing novel drugs based on a proteome-wide ligand and target discovery platform | |
| synthego.com | 2012 | Redwood, United States | $459.75M | – | CRISPR-engineered cell and gene therapies are developed for research applications. | |
| cibus.com | 2001 | San Diego, United States | $34.47M | 129 | Gene editing solutions are provided for agriculture. | |
| korrobio.com | 2018 | Cambridge, United States | $4M | 77 | RNA-editing technologies are provided for precision medicine applications. |
Detailed competitors of Revolution Bioengineering
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to Revolution Bioengineering
10 companies that operate in the same segment as Revolution Bioengineering (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 265 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Revolution Bioengineering
Revolution Bioengineering was founded in 2013 and raised its 1st funding round 1 year after it was founded.
Revolution Bioengineering is headquartered in Fort Collins, United States. It is registered at Fort Collins, Colorado, United States.
Revolution Bioengineering is a funded company, having raised a total of $60K across 1 funding round to date. The company's 1st funding round was a Seed of $60K, raised on Jul 2014.
Revolution Bioengineering was founded in 2013 in Fort Collins, United States, focusing on the bioengineering sector. Genetically modified Petunia Circadia plants are created by the company, enabling colour changes based on environmental conditions. Synthetic biology methods are employed to design novel biological functions in these flowers. Operations center on plant modification for adaptive traits, with the domain revolutionbio.co serving as the online presence.
Revolution Bioengineering's top competitors include Benson Hill, Sutro Biopharma and Cibus.
Revolution Bioengineering offers Color Changing Flowers and Gardening Tools.
Revolution Bioengineering has 1 investor. Key investors include SOSV.